Your Approach To USP <382> For Your Drug Product Packaging
![GettyImages-1178374751-syringe-gloves-vial-doctor GettyImages-1178374751-syringe-gloves-vial-doctor](https://vertassets.blob.core.windows.net/image/3138fa30/3138fa30-f038-4b35-9242-d8cf84315ec1/375_250-gettyimages_1178374751_syringe_gloves_vial_doctor.jpg)
The United States Pharmacopeia (USP) requirements for elastomeric components of container closure systems used for parenteral products are changing. The scope of USP <382> Elastomeric Component Functional Suitability in Parenteral Product Packaging/Delivery Systems1 introduces a paradigm shift away from testing elastomeric components individually by the supplier, as was done historically under USP <381> Elastomeric Components in Injectable Pharmaceutical Production Packaging/Delivery Systems,2 to a holistic evaluation of these components when assembled into drug product packaging and delivery systems. In addition, the testing is performed on the final product-package configuration as produced by the drug product manufacturer, using product-filled systems or systems filled with a suitable proxy, where applicable.
This article focuses on vial, syringe and cartridge container closure systems.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Drug Delivery Leader? Subscribe today.